These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28493863)

  • 1. Visceral leishmaniasis complicating idiopathic CD4+ T-cell lymphocytopenia: 2 case reports.
    Fox-Lewis A; Lockwood DNJ
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005412. PubMed ID: 28493863
    [No Abstract]   [Full Text] [Related]  

  • 2. Diffuse cutaneous dissemination of visceral leishmaniasis during human immunodeficiency virus (HIV) infection, despite negligible immunodeficiency: repeated failure of liposomal amphotericin B administration, followed by successful long-term pentamidine and paromomycin administration.
    Manfredi R; Marinacci G; Calza L; Passarini B
    Int J Antimicrob Agents; 2008 Jun; 31(6):590-2. PubMed ID: 18456464
    [No Abstract]   [Full Text] [Related]  

  • 3. Multiple relapses of visceral leishmaniasis in an adolescent with idiopathic CD4+ lymphocytopenia associated with novel immunophenotypic and molecular features.
    Prigione I; Castagnola E; Imberti L; Gambini C; Gradoni L; Dianzani U; Ramenghi U; Giacopelli F; Moretta A; Moretta L; Plebani A; Fischer A; Pistoia V
    Pediatr Infect Dis J; 2009 Feb; 28(2):161-3. PubMed ID: 19106781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of visceral leishmaniasis unresponsive to pentamidine with amphotericin B.
    Mishra M
    J Assoc Physicians India; 1995 Apr; 43(4):306. PubMed ID: 8713286
    [No Abstract]   [Full Text] [Related]  

  • 5. Case Report: Combination Therapy with Liposomal Amphotericin B, N-Methyl Meglumine Antimoniate, and Pentamidine Isethionate for Disseminated Visceral Leishmaniasis in a Splenectomized Adult Patient.
    Vechi HT; Sousa ASV; Cunha MAD; Shaw JJ; Luz KG
    Am J Trop Med Hyg; 2020 Feb; 102(2):268-273. PubMed ID: 31872796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphotericin B in visceral leishmaniasis.
    Jha BB
    Indian Pediatr; 1996 Nov; 33(11):971. PubMed ID: 9141838
    [No Abstract]   [Full Text] [Related]  

  • 7. Combination therapy with liposomal amphotericin b (ambisome), n-methylglucamine antimoniate (glucantime), and pentamidine isethionate in a refractory visceral leishmaniasis case.
    Gomes MAF; Medeiros LLC; Lobo FPD; Wanderley NRS; Matos APR; Jácome TDN; Monteiro MGL; Luz KG
    Rev Soc Bras Med Trop; 2018; 51(3):393-396. PubMed ID: 29972577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABLE: a new and improved amphotericin B for visceral leishmaniasis?
    Berman J
    Am J Trop Med Hyg; 2009 May; 80(5):689-90. PubMed ID: 19407106
    [No Abstract]   [Full Text] [Related]  

  • 9. [Subacute Mediterranean visceral leishmaniosis treated with a single injection of amphotericin B].
    Vandenbos F; Marty P; Rosenthal E; Delaunay P; Dellamonica P; Le Fichoux Y
    Presse Med; 2004 Sep; 33(15):1009-10. PubMed ID: 15523248
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful treatment of visceral leishmaniasis with liposomal amphotericin B.
    Lagler H; Matt U; Sillaber C; Winkler S; Graninger W
    Acta Biomed; 2006; 77 Suppl 2():22-5. PubMed ID: 16918063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of visceral leishmaniasis with intravenous pentamidine and oral fluconazole in an HIV-positive patient with chronic renal failure--a case report and brief review of the literature.
    Rybniker J; Goede V; Mertens J; Ortmann M; Kulas W; Kochanek M; Benzing T; Arribas JR; Fätkenheuer G
    Int J Infect Dis; 2010 Jun; 14(6):e522-5. PubMed ID: 19726213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of visceral leishmaniasis with high-dose amphotericin B diluted in fat emulsion: a case report.
    Herbrecht R; Sosa C; Himy R; Villard O
    Trans R Soc Trop Med Hyg; 1996; 90(3):322-3. PubMed ID: 8758094
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of kala-azar in India.
    Thakur CP
    Natl Med J India; 1992; 5(5):203-5. PubMed ID: 1338871
    [No Abstract]   [Full Text] [Related]  

  • 14. Challenges in the management of visceral leishmaniasis.
    Sundar S; Kumar A
    Indian Pediatr; 2005 Jun; 42(6):523-6. PubMed ID: 15995268
    [No Abstract]   [Full Text] [Related]  

  • 15. Kala-azar in Bihar.
    Prasad LS
    Indian J Pediatr; 1987; 54(1):103-10. PubMed ID: 3030932
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of amphotericin B colloidal dispersion in the treatment of Mediterranean visceral leishmaniasis in immunocompetent adult patients.
    Gaeta GB; Maisto A; Di Caprio D; Scalone A; Pasquale G; Felaco FM; Galante D; Gradoni L
    Scand J Infect Dis; 2000; 32(6):675-7. PubMed ID: 11200380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. U.S Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis.
    Berman JD
    Clin Infect Dis; 1999 Jan; 28(1):49-51. PubMed ID: 10391695
    [No Abstract]   [Full Text] [Related]  

  • 18. Visceral leishmaniasis during pregnancy: A rare case report from Greece.
    Panagopoulos P; Mitsopoulos V; Papadopoulos A; Theodorou S; Christodoulaki C; Aloupogiannis K; Papantoniou N
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005134. PubMed ID: 28207741
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of visceral leishmaniasis.
    Ozsoylu S
    Turk J Pediatr; 2003; 45(3):280. PubMed ID: 14696814
    [No Abstract]   [Full Text] [Related]  

  • 20. Amphotericin B for visceral leishmaniasis resistant to pentavalent antimonial drugs in AIDS.
    Rodilla F; Magraner J; Aznar J; Orovitg F; Alcácer F; Colomina J; Ferriols F
    Ann Pharmacother; 1994 Nov; 28(11):1305. PubMed ID: 7849352
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.